Main Page Side Effects Insurance Coverage Review Board

Does Blue Cross Blue Shield Colorado Cover Ozempic for Weight Loss?

Does Blue Cross Blue Shield Colorado Cover Ozempic? Colorado BCBS Coverage Guide 2026

If you live in Colorado wondering whether your Blue Cross Blue Shield plan covers Ozempic, the answer depends on your specific plan design. Anthem Blue Cross Blue Shield Colorado handles coverage for hundreds of thousands of Colorado residents, and the formulary treatment of Ozempic (the injectable GLP-1 receptor agonist) varies compared to other state BCBS affiliates.


Where Ozempic Sits on Anthem Blue Cross Blue Shield Colorado’s Drug List

Anthem Blue Cross Blue Shield Colorado operates a state-specific formulary that can diverge from national BCBS formularies. Currently, Ozempic is usually classified as Tier 4 (non-preferred specialty brand) across the majority of Anthem Blue Cross Blue Shield Colorado commercial plans.

What this translates to:

  • Prior authorization is mandatory across most benefit designs
  • Step therapy could be enforced — meaning you must try metformin or other first-line treatments first
  • Patient responsibility typically range between $50–$150/month based on benefit structure
  • Some Colorado employer-sponsored BCBS plans might classify Ozempic at a better tier

At retail price, Ozempic costs $850–$1,200 per month in Denver and across Colorado.


Ozempic Coverage for Medical Conditions in Colorado

Anthem Blue Cross Blue Shield Colorado’s coverage rules for Ozempic depend heavily on the reason for prescribing.

For type 2 diabetes (FDA-approved indication):

  • Getting covered is more likely
  • The majority of Colorado BCBS plans will approve Ozempic after PA review
  • PA criteria generally requires HbA1c levels above 7%

For weight loss (chronic weight management):

  • Approval is harder to obtain
  • Patients need to show BMI ≥30 (or ≥27 plus at least one weight-related comorbidity)
  • Some Colorado plans exclude weight loss drugs from formulary

How to Get Ozempic Approved by BCBS Colorado

Securing authorization for Ozempic through Anthem Blue Cross Blue Shield Colorado demands specific steps.

  1. Verify your plan’s formulary — Call the number on your ID card to check Ozempic’s tier placement and PA requirements on your specific plan
  2. Work with your prescriber send prior authorization — Attach diagnosis codes, lab results, and prior medication history
  3. Demonstrate failed prior therapies — Formulary compliance may need proof of inadequate response to multiple other medications first
  4. File an appeal — Anthem Blue Cross Blue Shield Colorado allows a formal appeals process plus external review through

A 2024 KFF survey found that around one-third of GLP-1 prior authorization requests face first-round denial but over 60% succeed through the appeals process.


Options When Coverage Falls Through

If Anthem Blue Cross Blue Shield Colorado denies Ozempic coverage, explore other paths:

  • Manufacturer savings programs — Novo Nordisk provides copay assistance that bring costs down to $25-$150/month for eligible commercially insured patients
  • Compounded semaglutide — Available through Colorado compounders at a fraction of brand cost, though not a formulary option
  • Consider formulary-preferred drugs — Anthem Blue Cross Blue Shield Colorado may prefer a different GLP-1
  • Colorado patient assistance programs — Look into Colorado offers supplemental prescription assistance for specialty drugs

Bottom Line for Colorado BCBS Members

Anthem Blue Cross Blue Shield Colorado may authorize Ozempic — getting approved is not automatic and depends on prior authorization, step therapy documentation, and medical necessity. Begin with reviewing your benefits and working with your provider to document medical necessity thoroughly.

References

  1. FDA Prescribing Information for GLP-1 receptor agonists. U.S. Food and Drug Administration. 2024.
  2. SURPASS and SURMOUNT clinical trial programs. Eli Lilly and Company. 2022-2025.
  3. SUSTAIN and STEP clinical trial programs. Novo Nordisk. 2017-2024.
  4. American Diabetes Association Standards of Care in Diabetes. 2025.
  5. American Society of Health-System Pharmacists (ASHP) Drug Information. 2025.